Holen Sie sich die Stockscreener-App
93.78
0.09%
0.14
Schlusskurs vom Vortag:
$93.64
Offen:
$93.38
24-Stunden-Volumen:
54,242
Relative Volume:
0.08
Marktkapitalisierung:
$5.54B
Einnahmen:
$1.33B
Nettoeinkommen (Verlust:
$120.04M
KGV:
45.75
EPS:
2.05
Netto-Cashflow:
$172.71M
1W Leistung:
-2.88%
1M Leistung:
-2.03%
6M Leistung:
-10.59%
1J Leistung:
+14.04%
1-Tages-Spanne:
$93.00
$93.87
1-Wochen-Bereich:
$91.73
$96.53
52-Wochen-Spanne:
$80.02
$111.45
Merit Medical Systems Inc Stock (MMSI) Company Profile
Firmenname
Merit Medical Systems Inc
Sektor
Telefon
(801) 253-1600
Adresse
1600 WEST MERIT PARK WAY, SOUTH JORDAN, UT
Vergleichen Sie MMSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MMSI
Merit Medical Systems Inc
|
93.78 | 5.70B | 1.33B | 120.04M | 172.71M | 2.05 |
|
ISRG
Intuitive Surgical Inc
|
549.46 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
170.28 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.18 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
245.34 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
29.81 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Merit Medical Systems Inc Stock (MMSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Eingeleitet | JP Morgan | Overweight |
| 2024-12-11 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-06-28 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-11 | Eingeleitet | CL King | Buy |
| 2024-02-07 | Eingeleitet | BofA Securities | Neutral |
| 2023-12-21 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-12-20 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2021-01-05 | Hochstufung | Needham | Hold → Buy |
| 2020-09-28 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-02-25 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-02-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-12-12 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-09-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-09-10 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Needham | Buy → Hold |
| 2019-07-26 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-10-02 | Bestätigt | Needham | Buy |
| 2018-08-07 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-07-24 | Bestätigt | Needham | Buy |
| 2018-06-01 | Bestätigt | Needham | Buy |
| 2018-05-18 | Bestätigt | SunTrust | Buy |
| 2018-04-26 | Bestätigt | Needham | Buy |
| 2018-04-20 | Eingeleitet | Needham | Buy |
| 2018-03-01 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-08-28 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2017-07-20 | Eingeleitet | BofA/Merrill | Buy |
| 2017-06-20 | Eingeleitet | SunTrust | Buy |
| 2017-04-05 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Merit Medical Systems Inc Aktie (MMSI) Neueste Nachrichten
Do Merit Medical Systems' (NASDAQ:MMSI) Earnings Warrant Your Attention? - Yahoo Finance
Have Merit Medical Systems Insiders Been Selling Stock? - simplywall.st
Merit Medical (MMSI) CEO Sells Significant Shareholding | MMSI S - GuruFocus
Merit Medical CEO sells $1.93M shares of shares - TipRanks
Merit Medical Systems CEO Fred Lampropoulos sells $1.93 million in stock - Investing.com
Q1 Earnings Highs And Lows: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks - Yahoo Finance
Here's How Much $1000 Invested In Merit Medical Systems 20 Years Ago Would Be Worth Today - Benzinga
Prostatic Artery Embolization Market Set to Witness Rising AdoptionMerit Medical, Boston Scientific - openPR.com
When the Price of (MMSI) Talks, People Listen - news.stocktradersdaily.com
Merit Medical Systems (MMSI) Target Price Raised to $110 by Pipe - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Amidst Recent De - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Amidst Recent Developments | MMSI Stock News - GuruFocus
Merit Medical Systems acquires Biolife Delaware in $120 million deal - MSN
Merit Medical Systems: A Quality Business Judged On Its Merits (NASDAQ:MMSI) - Seeking Alpha
Canaccord raises Merit Medical price target to $112 By Investing.com - Investing.com South Africa
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio - sharewise
Canaccord raises Merit Medical price target to $112 - Investing.com Australia
MMSI: Target Price Raised by Canaccord Genuity with Buy Rating M - GuruFocus
Manatee medical manufacturer acquired for $120 million - Business Observer
Merit buys hemostatic device maker Biolife for $120M - MedTech Dive
Merit Medical Systems (MMSI) Target Price Increased by Wells Fargo | MMSI Stock News - GuruFocus
Merit Medical acquires Biolife Delaware - Medical Buyer
Risks To Shareholder Returns Are Elevated At These Prices For Merit Medical Systems, Inc. (NASDAQ:MMSI) - simplywall.st
Merit Medical (MMSI) Price Target Raised by Canaccord Analyst | - GuruFocus
Merit Medical (MMSI) Sees Price Target Increase Following Acquis - GuruFocus
Interventional Neuroradiology Market Growth, Trends & - openPR.com
Merit Medical acquires fellow interventional radiology vendor Biolife for $120M - Radiology Business
Merit Medical acquires Biolife for enhanced hemostasis By Investing.com - Investing.com South Africa
Merit Medical Acquires Biolife Delaware for $120 Million - TipRanks
Merit Medical acquires Biolife for enhanced hemostasis - Investing.com Australia
Merit Medical Systems, Inc. acquired Biolife, LLC for $120 million. - marketscreener.com
MMSI: Analyst Reiterates Buy Rating with $108 Target | MMSI Stoc - GuruFocus
Merit Medical Buys Biolife Delaware for $120 Million - Medical Product Outsourcing
Merit Medical Systems, Inc. Updates Earning Guidance for the Fiscal Year Ending December 31,2025 - marketscreener.com
Merit Medical Systems (MMSI) Adjusts FY25 Revenue Expectations | - GuruFocus
Merit Medical (MMSI) Completes Acquisition of Biolife Delaware | - GuruFocus
Merit Medical (MMSI) Acquires Biolife Delaware in $120 Million D - GuruFocus
Merit Medical Systems Acquires Biolife Delaware For About $120 Mln; Confirms Annual Outlook - Nasdaq
Merit Medical Systems Buys Biolife Delaware - marketscreener.com
Merit Medical Acquires Biolife Delaware, L.L.C. | MMSI Stock News - GuruFocus
Merit Medical Acquires Biolife Delaware, L.L.C. - The Manila Times
Merit Medical Systems, Inc. Acquires Biolife Delaware, L.L.C. to Enhance Hemostasis Solutions Portfolio and Revenue Growth - Nasdaq
Merit Medical's $120M Biolife Acquisition Expands Global Hemostasis Portfolio with StatSeal Technology - Stock Titan
Merit Medical Systems Shareholders Approve Key Proposals - TipRanks
Zacks Research Issues Pessimistic Estimate for MMSI Earnings - Defense World
Reflecting On Medical Devices & SuppliesCardiology, Neurology, Vascular Stocks’ Q1 Earnings: Merit Medical Systems (NASDAQ:MMSI) - Yahoo Finance
Merit Medical Inks Deal for Ostial Solutions - Medical Product Outsourcing
Coating Process Spurs Warning Letter for Merit Medical - Medical Product Outsourcing
Merit Medical Expands Virginia Facility - Medical Product Outsourcing
Merit Medical Posts Better-Than-Expected Q3 Earnings - Medical Product Outsourcing
Merit Medical Posts Better-That-Expected Third-Quarter Earnings - Medical Product Outsourcing
Finanzdaten der Merit Medical Systems Inc-Aktie (MMSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.75%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):